Literature DB >> 34339808

Oxygen-glucose deprivation in neurons: implications for cell transplantation therapies.

Sebastiano Antonio Rizzo1, Oliver Bartley2, Anne E Rosser3, Ben Newland4.   

Abstract

Cell replacement therapies hold the potential to restore neuronal networks compromised by neurodegenerative diseases (such as Parkinson's disease or Huntington's disease), or focal tissue damage (via a stroke or spinal cord injury). Despite some promising results achieved to date, transplanted cells typically exhibit poor survival in the central nervous system, thus limiting therapeutic efficacy of the graft. Although cell death post-transplantation is likely to be multifactorial in causality, growing evidence suggests that the lack of vascularisation at the graft site, and the resulting ischemic host environment, may play a fundamental role in the fate of grafted cells. Herein, we summarise data showing how the deprivation of either oxygen, glucose, or both in combination, impacts the survival of neurons and review strategies which may improve graft survival in the central nervous system.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cell therapies; cell transplantation; graft survival; ischemia; neurodegenerative diseases; neuronal anaerobic glycolysis

Mesh:

Substances:

Year:  2021        PMID: 34339808     DOI: 10.1016/j.pneurobio.2021.102126

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  2 in total

1.  Nonfreezing Low Temperature Maintains the Viability of Menstrual Blood-Derived Endometrial Stem Cells Under Oxygen-Glucose Deprivation Through the Sustained Release of Autophagy-Produced Energy.

Authors:  Tongtong Chen; Shenghui Zhang; Hongzhang Jin; Xiaofei Fu; Lingrui Shang; Yilin Lu; Yuliang Sun; Badrul Hisham Yahaya; Yanli Liu; Juntang Lin
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

2.  Alpha-Ketoglutarate Alleviates Neuronal Apoptosis Induced by Central Insulin Resistance through Inhibiting S6K1 Phosphorylation after Subarachnoid Hemorrhage.

Authors:  Peng-Fei Ding; Qi Zhu; Bin Sheng; Heng Yang; Hua-Jie Xu; Tao Tao; Zheng Peng; Xiang-Xin Chen; Xiao-Jian Li; Yan Zhou; Hua-Sheng Zhang; Yong-Yue Gao; Zong Zhuang; Chun-Hua Hang; Wei Li
Journal:  Oxid Med Cell Longev       Date:  2022-08-25       Impact factor: 7.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.